Laci-2 trial results published
Laci-2 trial results published
The results of the Lacunar intervention 2 Trial (Laci-2) have been published in Lancet Neurology
This randomised clinical trial tested the feasibility and effects of one year of isosorbide mononitrate (ISMN) and cilostazol treatment in 363 participants with lacunar stroke. The results indicate that these widely available drugs may reduce adverse vascular and cognitive outcomes. Further studies are now in preparation to validate these findings. Read the results in more detail here
Read more about the study on the BHF trials website here